Advertisement

Loading...

Simply Solventless Concentrates

HASH.VTSX
Healthcare
Drug Manufacturers - Specialty & Generic
$0.04
$-0.01(-18.18%)
Canadian Market opens in 16h 25m

Simply Solventless Concentrates Fundamental Analysis

Simply Solventless Concentrates (HASH.V) shows moderate financial fundamentals with a PE ratio of 1.52, profit margin of 13.57%, and ROE of 14.04%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position17.31%
PEG Ratio-0.05
Current Ratio2.53

Areas of Concern

Operating Margin-3.80%
We analyze HASH.V's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 61.7/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C+
61.7/100

We analyze HASH.V's fundamental strength across five key dimensions:

Efficiency Score

Weak

HASH.V struggles to generate sufficient returns from assets.

ROA > 10%
6.91%

Valuation Score

Excellent

HASH.V trades at attractive valuation levels.

PE < 25
1.52
PEG Ratio < 2
-0.05

Growth Score

Moderate

HASH.V shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

HASH.V maintains a strong and stable balance sheet.

Debt/Equity < 1
0.48
Current Ratio > 1
2.53

Profitability Score

Weak

HASH.V struggles to sustain strong margins.

ROE > 15%
14.04%
Net Margin ≥ 15%
13.57%
Positive Free Cash Flow
No

Key Financial Metrics

Is HASH.V Expensive or Cheap?

P/E Ratio

HASH.V trades at 1.52 times earnings. This suggests potential undervaluation.

1.52

PEG Ratio

When adjusting for growth, HASH.V's PEG of -0.05 indicates potential undervaluation.

-0.05

Price to Book

The market values Simply Solventless Concentrates at 0.20 times its book value. This may indicate undervaluation.

0.20

EV/EBITDA

Enterprise value stands at -0.99 times EBITDA. This is generally considered low.

-0.99

How Well Does HASH.V Make Money?

Net Profit Margin

For every $100 in sales, Simply Solventless Concentrates keeps $13.57 as profit after all expenses.

13.57%

Operating Margin

Core operations generate -3.80 in profit for every $100 in revenue, before interest and taxes.

-3.80%

ROE

Management delivers $14.04 in profit for every $100 of shareholder equity.

14.04%

ROA

Simply Solventless Concentrates generates $6.91 in profit for every $100 in assets, demonstrating efficient asset deployment.

6.91%

Following the Money - Real Cash Generation

Operating Cash Flow

Simply Solventless Concentrates generates limited operating cash flow of $-1.88M, signaling weaker underlying cash strength.

$-1.88M

Free Cash Flow

Simply Solventless Concentrates generates weak or negative free cash flow of $-1.93M, restricting financial flexibility.

$-1.93M

FCF Per Share

Each share generates $-0.02 in free cash annually.

$-0.02

FCF Yield

HASH.V converts -30.39% of its market value into free cash.

-30.39%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

1.52

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.05

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.20

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.21

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.48

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.53

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.14

vs 25 benchmark

ROA

Return on assets percentage

0.07

vs 25 benchmark

ROCE

Return on capital employed

-0.02

vs 25 benchmark

How HASH.V Stacks Against Its Sector Peers

MetricHASH.V ValueSector AveragePerformance
P/E Ratio1.5227.91 Better (Cheaper)
ROE14.04%687.00% Weak
Net Margin13.57%-45285.00% (disorted) Strong
Debt/Equity0.480.33 Weak (High Leverage)
Current Ratio2.532795.76 Strong Liquidity
ROA6.91%-13557.00% (disorted) Weak

HASH.V outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Simply Solventless Concentrates's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ